The present invention provides {HEAD ~ novel compounds} which bind to and are agonists, antagonists or {TAIL ~ inverse agonists} of the CB2 receptor 
bind to
The present invention provides { HEAD ~ novel compounds } which bind to and are agonists , antagonists or { TAIL ~ inverse agonists } of the CB2 receptor
OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH REL REL OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH